A significant trend is evident in the enhancement of the sensation of incomplete defecation (reduction from 1.26 to 0.22), alongside the categories of constipation and diarrhea, which both exhibit values below 0.2 post-treatment.
← all excerpts
Patient-Reported Epigastric Symptom Dynamics During Trimebutine Maleate Treatment: A Post-Marketing Study.
1
—
—